TapewireFind a company

person · Reporting owner

Smith Darrin

Disclosed activity across 1 company

Tapewire entity
970
SEC CIK
0002104848

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Sabra Health Care REIT, Inc.SBRA · Entity 886Executive VP, CIO & SecretaryAugust 31, 2026September 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Sabra Health Care REIT, Inc.

Report date August 31, 2026 · Filed September 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect116,919 Reported balance After 2026-08-31 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-08-31 · Grant · Acquired 495 · Balance 116,919

F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2: Includes 34,182 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2: Includes 34,182 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 31, 2026 Filed Sep 2, 2026 21:49 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 495 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000012 · wk-form4_1788385762.xml · nonDerivative · entry 1

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,919

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 34,182 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 19:13 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 501 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000010 · wk-form4_1780427586.xml · nonDerivative · entry 1

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,424

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 33,687 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 19:23 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 478 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000008 · wk-form4_1772565818.xml · nonDerivative · entry 1

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,923

F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

F2 · balance_after: Includes 33,186 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 6,390 $19.15 $122,368.50
Disclosure

SEC source: 0002104848-26-000006 · wk-form4_1770946103.xml · nonDerivative · entry 4

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,445

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person.

F4 · balance_after: Includes 32,708 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 14,088 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000006 · wk-form4_1770946103.xml · nonDerivative · entry 3

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,835

F3 · shares: Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on March 19, 2025, including 896 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of PSUs earned was 168.4% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2025 and ending December 31, 2025.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 2,927 $19.15 $56,052.05
Disclosure

SEC source: 0002104848-26-000006 · wk-form4_1770946103.xml · nonDerivative · entry 2

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,747

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person.

Read SEC document
February 10, 2026 Filed Feb 13, 2026 01:28 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 5,483 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000006 · wk-form4_1770946103.xml · nonDerivative · entry 1

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,674

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 1,152 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025.

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:09 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 4,963 $19.61 $97,324.43
Disclosure

SEC source: 0002104848-26-000004 · wk-form4_1768262970.xml · nonDerivative · entry 3

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,191

F3 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person

F4 · balance_after: Includes 32,708 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:09 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 Tax withholdingCommon Stock 5,432 $19.61 $106,521.52
Disclosure

SEC source: 0002104848-26-000004 · wk-form4_1768262970.xml · nonDerivative · entry 2

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,154

F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

Read SEC document
January 08, 2026 Filed Jan 13, 2026 00:09 UTC Sabra Health Care REIT, Inc. SBRA · Entity 886 GrantCommon Stock 13,710 $0.00 $0.00
Disclosure

SEC source: 0002104848-26-000004 · wk-form4_1768262970.xml · nonDerivative · entry 1

Smith Darrin · CIK 0002104848 · Executive VP, CIO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,586

F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to relative total stockholder return-based stock unit ("TSR units") awards granted on December 27, 2022, including 2,882 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 8, 2026 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of preselected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.